Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

UroGen Pharma to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022


UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report third quarter 2022 financial results on Thursday, November 10, 2022, prior to the open of the market. The announcement will be followed by a live audio webcast and conference call at 10:00 AM Eastern Time.

A live public webcast of the earnings conference call can be accessed on UroGen's Investor Relations website. Following the live webcast, a replay will be available on the site for approximately 30 days.

About UroGen Pharma Ltd.

UroGen is a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options. UroGen has developed RTGeltm reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen's sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGen's first commercial product Jelmyto® (mitomycin) for pyelocaliceal solution and investigational treatment UGN-102 (mitomycin) for intravesical solution are designed to ablate tumors by non-surgical means. UroGen is headquartered in Princeton, NJ with operations in Israel. Visit www.urogen.com to learn more or follow us on Twitter, @UroGenPharma.


These press releases may also interest you

at 19:13
BLADEX ANNOUNCES QUARTERLY DIVIDEND PAYMENT FOR FIRST QUARTER 2024
Banco Latinoamericano de Comercio Exterior, S.A. ("Bladex" or the "Bank"), announced today its Board of Directors' approval of a quarterly cash dividend of US$0.50 per share corresponding to the first quarter of 2024. The cash dividend is payable...

at 19:13
TSX Venture Exchange Stock Maintenance Bulletins
TSX VENTURE COMPANIES BULLETIN V2024-1134 GOLD79 MINES LTD. ("AUU")BULLETIN TYPE: ConsolidationBULLETIN DATE: April 18, 2024TSX Venture Tier 2 Company Pursuant to a resolution passed by directors on April 2, 2024, the Company has consolidated its...

at 19:09
Media Advisory - Deputy Prime Minister's itinerary for Friday, April 19, 2024
Note: All times local. Toronto, Ontario Private meetings. 12:30 p.m. The Deputy Prime Minister will tour a research lab and discuss Budget 2024's investments to support research, students, innovation, and productivity. A media availability will...

at 19:00
WorldTrips Wins Gold 2024 Stevie® Award
WorldTrips, a part of the Tokio Marine HCC group of companies, has won a Gold award in the Sales Distinction of the Year ? Computer Software category in the 18th Annual Stevie® Awards for Sales & Customer Service.The awards are presented by the...

at 18:55
Bonterra Announces $4M Brokered Private Placement
Bonterra Resources Inc. ("Bonterra" or the "Company") is pleased to announce that it has entered into an agreement with Eight Capital as lead agent (the "Agent") in connection with a "best efforts" private placement of up...

at 18:52
Invest in Bogota ventures into Miami's thriving entrepreneurial scene for investment opportunities
In celebration of Miami Tech Month, the city of Miami is hosting a variety of events, welcoming venture capitalists, entrepreneurs, and technology innovators from around the globe. During this week, the city hosted Startup OLÉ, one of Europe's...

More news about Business...


News published on and distributed by: